St. Louis startup developing cancer-fighting drug raises $21M
The St. Louis biotechnology startup plans to use its new funding to advance clinical trials of its lead drug candidate.
The St. Louis biotechnology startup plans to use its new funding to advance clinical trials of its lead drug candidate.